Head of Patient Advocacy, Global Product Development, Pfizer Rare Disease

Patient advocacy and disease awareness are life-long passions for Dr Nicolas Garnier.

Nicolas is a scientist by training and a published author. He completed his Master’s degree in Cancer Genetics at Denis Diderot University (Paris, France), before completing his PhD degree in Experimental Medicine at McGill University (Montreal, Canada) in 2013.

He then studied the functional genomics of pediatric leukemia at Sainte-Justine Hospital (Montreal, Canada) as a Postdoctoral Fellow before joining Pfizer Canada Medical Affairs in 2015. He then took on the role of Senior Manager Access for Pfizer Canada Rare Disease, where he was responsible for Market Access, HEOR, as well as Policy.

He has built strong relationships with Patient Groups in the Rare Disease and the Oncology space.

In his current role as Head of Patient Advocacy, Global Product Development, Nicolas helps Pfizer clinical teams integrate the unique expertise of patients, caregivers and advocates to design and conduct development programs that positively impact the lives of patients.

Nicolas is also leading the SCREEN4CARE public-private-patient IMI consortium on behalf of EFPIA and hopes to address one of the major hurdles for Rare Disease families: the diagnosis journey.